TickerFacts.

AEON Biopharma, Inc. (AEON): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$12.72M
Year ended 2025-12-31
-$19.78M
Trailing 12 months to 2026-06-30
$73.08M2022-12-31: -$48.36M2024-12-31: $73.08M2025-12-31: -$12.72M-$12.72M
2022-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$12.72Mn/m2026-03-30, From 2025-01-01
2024-12-31$73.08Mn/a2026-03-30, From 2024-01-01
No annual figure between 2022-12-31 and 2024-12-31.
2022-12-31-$48.36Mn/a2024-05-14, From 2022-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
AEON Biopharma, Inc. (AEON)2025-12-31-$12.72Mn/m
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31-$7.72Mn/m
Quantum Cyber N.V. (QUCY)2025-12-31-$15.52Mn/m
Ernexa Therapeutics Inc. (ERNA)2025-12-31-$9.25Mn/m
Petros Pharmaceuticals, Inc. (PTPI)2024-12-31-$1.80Mn/m
Enveric Biosciences, Inc. (ENVB)2025-12-31-$8.57Mn/m
Azitra, Inc. (AZTR)2025-12-31-$10.83Mn/m
GeoVax Labs, Inc. (GOVX)2025-12-31-$21.57Mn/m
International Stem Cell Corp (ISCO)2025-12-31-$48.0Kn/m

Compare AEON, SXTP, QUCY, ERNA side by side · Screen every company in Pharmaceutical Preparations ↗